[Duration of treatment in psoriasis using combined anthraline salicylic acid petrolatum].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009824:Ointments / Q000627:therapeutic use*; D010577:Petrolatum / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy*; D012075:Remission, Spontaneous; D012459:Salicylates / Q000627:therapeutic use; D012737:Sex Factors; D013997:Time Factors; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D004338:Drug Combinations; D009824:Ointments; D012459:Salicylates; D062367:ortho-Aminobenzoates; D010577:Petrolatum
Behandlungsdauer bei kombinierter Cignolin-Salicylsäure-Vaseline-Behandlung bei Psoriasis.